Nadine Krüger

Has grant

Head of Unit

German Primate Center

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

ANI-CoV - Haustiere als potenzielle Vektoren für die Übertragung von SARS-CoV-2 - Teilvorhaben A, DPZ , Untersuchung der Empfänglichkeit von Haus- und Nutztieren

Open Date: 2020-06-01

Close Date: 2021-11-30

Grant: Close

Role of the surface glycoproteins of a bat-derived mumps virus concerning viral entry, replication, tropism, and virulence

Open Date: 2016-01-01

Close Date: 2020-09-01

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Stefan A. Laufer

Eberhard Karls Universität Tübingen

GERMANY

View details

Stefan Pöhlmann

Head of Infection Biology Unit

German Primate Center

GERMANY

View details

Thanigaimalai Pillaiyar

Eberhard Karls Universität Tübingen

GERMANY

View details

Thales Kronenberger

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nadine Krüger

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

SARS-CoV-2 infection induces adaptive NK cell responses by spike protein-mediated induction of HLA-E expression.

Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models

Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models

Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity

Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity (vol 7, pg 493, 2024)

Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19

Development of novel ligands against SARS‐CoV‐2 Mpro enzyme: an in silico and in vitro Study

Development of novel ligands against SARS-CoV-2 M<SUP>pro</SUP> enzyme: an <i>in silico</i> and <i>in vitro</i> Study

Discovery of Polyphenolic Natural Products as SARS-CoV-2 M<SUP>pro</SUP> Inhibitors for COVID-19

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein

Collaborators (4)

Stefan A. Laufer

Stefan Pöhlmann

Thanigaimalai Pillaiyar

Thales Kronenberger

Make your next move.